Silexion Therapeutics Corp. (SLXN)
1.53
-0.03
(-1.92%)
USD |
NASDAQ |
Mar 18, 16:00
1.62
+0.09
(+5.88%)
After-Hours: 07:04
Silexion Therapeutics Shareholders Equity (Quarterly) : 2.603M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Compugen Ltd. | 102.73M |
| Pluri, Inc. | -14.61M |
| BioLineRx Ltd. | 19.53M |
| XTL Biopharmaceuticals Ltd. | 5.435M |
| Can-Fite BioPharma Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.215M |
| Total Liabilities (Quarterly) | 4.612M |
| Debt to Equity Ratio | 0.7822 |
| Current Ratio | 2.406 |
| Net Debt Paydown Yield | 7.58% |